The latter finding rules out the possibility that the absence of IgM downregulates CD5 expression and supports progression to leukemia as a cause for the decreased numbers of CD19+CD5+ CLL-like cells in the IgM–/– TCL1 animals. This evidence concerns the gene CD19 and leukemia.